医学
优势比
置信区间
科克伦图书馆
随机对照试验
相对风险
早期目标导向治疗
梅德林
荟萃分析
肺炎
内科学
重症监护医学
感染性休克
败血症
法学
政治学
严重败血症
作者
Matthew Chong,Yongjun Wang,Nicolas M. Berbenetz,I. McConachie
标识
DOI:10.1097/eja.0000000000000778
摘要
Peri-operative modern goal-directed therapy reduces morbidity and mortality. Importantly, the quality of evidence was low to very low (e.g. Grading of Recommendations, Assessment, Development and Evaluation scoring), and there was much clinical heterogeneity among the goal-directed therapy devices and protocols. Additional well designed and adequately powered trials on peri-operative goal-directed therapy are necessary.
科研通智能强力驱动
Strongly Powered by AbleSci AI